Provectus Biopharmaceuticals, Inc. (PVCT) stock
PVCTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.05+0.00 (+0.39%)
Close on Oct 19, 2026Market cap $20.55MP/E –Yield –
Provectus Biopharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2011 it was $0.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2011 | Dec 31, 2011 | $0 | – |
See a number that looks wrong?